Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | 609A |
Synonyms | |
Therapy Description |
609A is a recombinant immunoglobulin G4 (IgG4) kappa monoclonal antibody against PD-1 (PDCD1) (NCI Thesaurus). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
609A | Immune Checkpoint Inhibitor 147 PD-L1/PD-1 antibody 117 | 609A is a recombinant immunoglobulin G4 (IgG4) kappa monoclonal antibody against PD-1 (PDCD1) (NCI Thesaurus). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03950297 | Phase I | 609A | Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A | Unknown status | USA | 0 |